Polypharmacy and potentially inappropriate medication in elderly of Northern Portugal
Autor(a) principal: | |
---|---|
Data de Publicação: | 2015 |
Outros Autores: | , |
Idioma: | eng |
Título da fonte: | Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) |
Texto Completo: | http://hdl.handle.net/10198/16321 |
Resumo: | Introduction: The growing aging of population and increasing prevalence of chronic diseases require the simultaneous use of drugs, lead to the issue of polypharmacy and potentially interactions and inappropriate use. Aim: To characterize polymedicated elderly and related factors, identify potentially interactions and inappropriate medication in elderly. Material and Methods: This cross-sectional study was based on a questionnaire applied to 69 elderly (≥65 years) from northern Portugal. It was considered as polymedicated seniors taking ≥5 drugs. Beers list and the Delafuente classification were used to evaluate the therapeutic and possible interactions. It was used descriptive statistics and a model of binary regression, with a significance of 5%. The study was approved by Ethics Committee. Results: The sample consisted mainly of males (53.6% vs. 46.4%), aged between 66 and 99 years (mean 82.01), while 65.2% have more than 80 years. However, most elderly are not polymedicated (58%), on average 4.61 different drugs are administered per day (maximum=19), antihypertensives (36.2%) and antacids (30.04%) are the most prescribed. Hypertension and depression increase the risk of polymedication eightfold (p=0.004) and fivefold (p=0.011) respectively. Female gender seems increase the risk of polypharmacy threefold, although not statistically significant (p=0.102), and regarding age, the older age group (>85 years) seems reduces the risk of polypharmacy in 0.6 fold, but also not statistically significant. According with Delafuente classification, 1.4% of elderly has potentially drug interactions (Omeprazole and Iron salts). According to the list of Beers, 5.8% of seniors take drugs that classified as having some indications (hydroxyzine, amitriptyline). Conclusions: Regarding polypharmacy, 42% of elderly are polymedicated with an average of about 5 different drugs per day, antihypertensives and antacids the most prescribed. Hypertension and depression are highly associated with polypharmacy. We identified one potentially drug interaction and about 6% of elderly taking drugs that classified as having some indications. |
id |
RCAP_28c1d6dfbcf5b2974fbd3e2462343d9a |
---|---|
oai_identifier_str |
oai:bibliotecadigital.ipb.pt:10198/16321 |
network_acronym_str |
RCAP |
network_name_str |
Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) |
repository_id_str |
https://opendoar.ac.uk/repository/7160 |
spelling |
Polypharmacy and potentially inappropriate medication in elderly of Northern PortugalBeers listDelafuente classificationElderlyInappropriate medication in elderlyMedication interactionsPolypharmacyIntroduction: The growing aging of population and increasing prevalence of chronic diseases require the simultaneous use of drugs, lead to the issue of polypharmacy and potentially interactions and inappropriate use. Aim: To characterize polymedicated elderly and related factors, identify potentially interactions and inappropriate medication in elderly. Material and Methods: This cross-sectional study was based on a questionnaire applied to 69 elderly (≥65 years) from northern Portugal. It was considered as polymedicated seniors taking ≥5 drugs. Beers list and the Delafuente classification were used to evaluate the therapeutic and possible interactions. It was used descriptive statistics and a model of binary regression, with a significance of 5%. The study was approved by Ethics Committee. Results: The sample consisted mainly of males (53.6% vs. 46.4%), aged between 66 and 99 years (mean 82.01), while 65.2% have more than 80 years. However, most elderly are not polymedicated (58%), on average 4.61 different drugs are administered per day (maximum=19), antihypertensives (36.2%) and antacids (30.04%) are the most prescribed. Hypertension and depression increase the risk of polymedication eightfold (p=0.004) and fivefold (p=0.011) respectively. Female gender seems increase the risk of polypharmacy threefold, although not statistically significant (p=0.102), and regarding age, the older age group (>85 years) seems reduces the risk of polypharmacy in 0.6 fold, but also not statistically significant. According with Delafuente classification, 1.4% of elderly has potentially drug interactions (Omeprazole and Iron salts). According to the list of Beers, 5.8% of seniors take drugs that classified as having some indications (hydroxyzine, amitriptyline). Conclusions: Regarding polypharmacy, 42% of elderly are polymedicated with an average of about 5 different drugs per day, antihypertensives and antacids the most prescribed. Hypertension and depression are highly associated with polypharmacy. We identified one potentially drug interaction and about 6% of elderly taking drugs that classified as having some indications.European Association for Clinical Pharmacology and TherapeuticsBiblioteca Digital do IPBPinto, Isabel C.Pereira, Fernando A.Mateos-Campos, R.2018-03-15T16:16:35Z20152015-01-01T00:00:00Zconference objectinfo:eu-repo/semantics/publishedVersionimage/jpeghttp://hdl.handle.net/10198/16321engPinto, Isabel C.; Pereira, Fernando; Mateos-Campos, R. (2015). Polypharmacy and potentially inappropriate medication in elderly of Northern Portugal. In 12th Congress of the European Association for Clinical Pharmacology and Therapeutics. Madridinfo:eu-repo/semantics/openAccessreponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiainstacron:RCAAP2025-02-25T12:06:18Zoai:bibliotecadigital.ipb.pt:10198/16321Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireinfo@rcaap.ptopendoar:https://opendoar.ac.uk/repository/71602025-05-28T11:33:04.960146Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiafalse |
dc.title.none.fl_str_mv |
Polypharmacy and potentially inappropriate medication in elderly of Northern Portugal |
title |
Polypharmacy and potentially inappropriate medication in elderly of Northern Portugal |
spellingShingle |
Polypharmacy and potentially inappropriate medication in elderly of Northern Portugal Pinto, Isabel C. Beers list Delafuente classification Elderly Inappropriate medication in elderly Medication interactions Polypharmacy |
title_short |
Polypharmacy and potentially inappropriate medication in elderly of Northern Portugal |
title_full |
Polypharmacy and potentially inappropriate medication in elderly of Northern Portugal |
title_fullStr |
Polypharmacy and potentially inappropriate medication in elderly of Northern Portugal |
title_full_unstemmed |
Polypharmacy and potentially inappropriate medication in elderly of Northern Portugal |
title_sort |
Polypharmacy and potentially inappropriate medication in elderly of Northern Portugal |
author |
Pinto, Isabel C. |
author_facet |
Pinto, Isabel C. Pereira, Fernando A. Mateos-Campos, R. |
author_role |
author |
author2 |
Pereira, Fernando A. Mateos-Campos, R. |
author2_role |
author author |
dc.contributor.none.fl_str_mv |
Biblioteca Digital do IPB |
dc.contributor.author.fl_str_mv |
Pinto, Isabel C. Pereira, Fernando A. Mateos-Campos, R. |
dc.subject.por.fl_str_mv |
Beers list Delafuente classification Elderly Inappropriate medication in elderly Medication interactions Polypharmacy |
topic |
Beers list Delafuente classification Elderly Inappropriate medication in elderly Medication interactions Polypharmacy |
description |
Introduction: The growing aging of population and increasing prevalence of chronic diseases require the simultaneous use of drugs, lead to the issue of polypharmacy and potentially interactions and inappropriate use. Aim: To characterize polymedicated elderly and related factors, identify potentially interactions and inappropriate medication in elderly. Material and Methods: This cross-sectional study was based on a questionnaire applied to 69 elderly (≥65 years) from northern Portugal. It was considered as polymedicated seniors taking ≥5 drugs. Beers list and the Delafuente classification were used to evaluate the therapeutic and possible interactions. It was used descriptive statistics and a model of binary regression, with a significance of 5%. The study was approved by Ethics Committee. Results: The sample consisted mainly of males (53.6% vs. 46.4%), aged between 66 and 99 years (mean 82.01), while 65.2% have more than 80 years. However, most elderly are not polymedicated (58%), on average 4.61 different drugs are administered per day (maximum=19), antihypertensives (36.2%) and antacids (30.04%) are the most prescribed. Hypertension and depression increase the risk of polymedication eightfold (p=0.004) and fivefold (p=0.011) respectively. Female gender seems increase the risk of polypharmacy threefold, although not statistically significant (p=0.102), and regarding age, the older age group (>85 years) seems reduces the risk of polypharmacy in 0.6 fold, but also not statistically significant. According with Delafuente classification, 1.4% of elderly has potentially drug interactions (Omeprazole and Iron salts). According to the list of Beers, 5.8% of seniors take drugs that classified as having some indications (hydroxyzine, amitriptyline). Conclusions: Regarding polypharmacy, 42% of elderly are polymedicated with an average of about 5 different drugs per day, antihypertensives and antacids the most prescribed. Hypertension and depression are highly associated with polypharmacy. We identified one potentially drug interaction and about 6% of elderly taking drugs that classified as having some indications. |
publishDate |
2015 |
dc.date.none.fl_str_mv |
2015 2015-01-01T00:00:00Z 2018-03-15T16:16:35Z |
dc.type.driver.fl_str_mv |
conference object |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10198/16321 |
url |
http://hdl.handle.net/10198/16321 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
Pinto, Isabel C.; Pereira, Fernando; Mateos-Campos, R. (2015). Polypharmacy and potentially inappropriate medication in elderly of Northern Portugal. In 12th Congress of the European Association for Clinical Pharmacology and Therapeutics. Madrid |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
image/jpeg |
dc.publisher.none.fl_str_mv |
European Association for Clinical Pharmacology and Therapeutics |
publisher.none.fl_str_mv |
European Association for Clinical Pharmacology and Therapeutics |
dc.source.none.fl_str_mv |
reponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia instacron:RCAAP |
instname_str |
FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) |
collection |
Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) |
repository.name.fl_str_mv |
Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia |
repository.mail.fl_str_mv |
info@rcaap.pt |
_version_ |
1833592010193240064 |